For the past three decades, assisted reproductive technologies (ART) have revolutionized infertility treatments. The use of ART is thought to be safe. However, early investigations suggested that children born as a result of ART had higher risk of diseases with epigenetic etiologies, including imprinting disorders caused by a lack of maternal methylation at imprinting control elements. In addition, large epidemiology studies have highlighted an increased risk of obstetric complications, including severe intrauterine growth restriction (IUGR) in babies conceived using ART. It is plausible that the increased frequency of IUGR may be due to abnormal imprinting because these transcripts are key for normal fetal growth and development. To address this, we have collected a large cohort of placenta and cord blood samples from ART conceptions and compared the imprinting status with appropriate non-ART population. Using a custom DNA methylation array that simultaneously quantifies 25 imprinted differentially methylated regions, we observed similar epigenetic profiles between groups. A multiplex Sequenom iPLEX allelic expression assay revealed monoallelic expression for 11 imprinted transcripts in our placenta cohort. We also observe appropriate gestational agedependent methylation dynamics at retrotransposable elements and promoters associated with growth genes in ART placental biopsies. This study confirms that children conceived by ART do not show variability in imprinted regulation and that loss-ofimprinting is not commonly associated with nonsyndromic IUGR or prematurity.
INTRODUCTION
On 25 July 1978, Dr. Patrick Steptoe and Dr. Robert Edwards revolutionized reproductive medicine, changing the lives of thousands of couples, whilst simultaneously initiating stem cell research with the successful application of in vitro fertilization (IVF). While the techniques used in reproductive medicine have evolved over the past 35 yr, little is known about what dictates their success; morphological perfect preimplantation embryos fail to implant, while chaotic discarded embryos can generate pluripotent stem cell lines. In both cases, while the DNA content derived from the gametes is normal, its organization may be altered, with abnormal embryonic epigenetic profiles having been implicated in IVF success and embryonic stem cell stability.
The oocyte and sperm contain specific DNA-methylation signatures that are largely reprogrammed during preimplantation development [1, 2] . Discrete DNA elements known as imprinted differentially methylated regions (DMRs) regulate the parent-of-origin monoallelic expression associated with imprinted transcripts [3] . These elements retain their parental methylation asymmetries during the oocyte to embryo transition and subsequently throughout somatic development [1, 4, 5] . Loss of maternally derived methylation at the KvDMR1 and SNRPN DMRs has been observed at higher rates after assisted reproductive technologies (ART), resulting in Beckwith-Wiedemann and Angelman syndromes (BWS and AS), respectively [6] [7] [8] [9] [10] . It has also been suggested that such epigenetic deregulation could potentially manifest as an increased propensity for childhood cancer, including retinoblastoma, which may be due in part, to defective RB1 imprinting [11] . However, large epidemiological studies in various European countries did not observe an increased frequency of these imprinting disorders in children conceived by ART despite recording increased incidence of other developmental disturbances [12] [13] [14] [15] .
It is currently unknown if additional imprinted genes could be susceptible to deregulation because the majority of these transcripts are not associated with specific phenotypes. Assessments after uneventful pregnancies following ART have observed some imprinted methylation defects, including isolated hypomethylation of the L3MBTL1 DMR [16] .
Several large epidemiological studies have revealed increased risk of both intrauterine growth restriction (IUGR) and/ or prematurity in babies following ART. In one study, data from 42 463 babies conceived by ART revealed a 2.6-fold increase for low (,2.5kg) or very low (,1.5kg) birth weight for singleton births [17] . Given that imprinted genes have been shown to influence human fetal and prenatal growth [18] [19] [20] [21] [22] , it is plausible that imprinting defects could be responsible, at least in part, for these observations. To date, no study has systematically assessed if the imprintome is epigenetically stable in newborns resulting from complicated pregnancies following ART. To address this, we have collected a large cohort of placenta and cord blood samples from spontaneously conceived newborns and from pregnancies conceived following ART. This sample cohort includes tissues from numerous IUGR, premature, and multiple births. To quantitate the methylation in these samples, we used pyrosequencing of DNA repeat elements (Alu Yb8, LINE-1, and a-satellites) and a custom Illumina Goldengate methylation array that simultaneously determines methylation at 25 imprinted DMRs. In samples heterozygous for exonic single nucleotide polymorphisms (SNPs), we also assessed allelic expression of imprinted transcripts using a quantitative multiplex Sequenom iPLEX expression assay. Using these techniques, we fail to observe variability in allelic methylation at imprinted DMRs, and all the informative expressed SNPs were monoallelically expressed. The expected gestational age-dependent increases in methylation at retrotransposable elements and gene promoters (VEGFA, PLA2G2A, and SLC2A3 [previously known as GLUT3]) were also observed in ART placenta samples, suggesting that epigenetic dynamics are normal as well.
MATERIALS AND METHODS
A cohort of 194 human placenta samples, 68 with corresponding maternal and cord bloods, were collected at Hospital St Joan De Deu and Dexeus Hospital (Barcelona, Spain) of which 110 were hybridized to our custom methylation array. Gestational age, birth and placental weights, and neonatal complications were documented after delivery. Detailed clinical information for each sample is summarized in Table 1 . Both DNA and RNA extractions and cDNA synthesis were carried out as previously described [23] . All the mothers provided informed consent for themselves and their child prior to participating in the study. Ethical approval for collecting blood and placental samples was granted by the ethical committees of Hospital St Joan De Deu Ethics Committee (Study number 35/07), Hospital Dexeus (ID017/09), and Bellvitge Institute for Biomedical Research (PR006/08).
DNA-Methylation Analysis
Approximately 2.5 lg DNA was subjected to sodium bisulphite treatment and purified using the EZ GOLD methylation kit (ZYMO) and methylation array analysis. A custom Illumina Goldengate methylation array was designed using Veracode technology [24] . The DNA sequence comprising the regions of interest was submitted for Goldengate methylation array scoring (GGMA), where a list of assays designed to specific CpG dinucleotides was generated. The array hybridization was performed by the genotype service at Centro Nacional de Investigaciones Oncologicas (Madrid, Spain) using Illumina supplied reagents and protocols. After probe intensity normalization using Methylumi, b-values representing methylation levels were generated for every probe. To ensure that the array could detect appropriate changes in DNA methylation at imprinted DMRs, we performed experiments using DNA samples from genomewide uniparental disomies (UPDs) as well as UPD for individual chromosomes [24] . The initial methylation data were filtered to exclude poor quality measurements, defined as probes with detection P value of .0.01 in .10% of samples. The filtered dataset corresponded to 378 probes, with 67 mapping to 25 imprinted DMRs (two to four independent probes), with the remainder located in the promoters of 241 transcripts (one to two probes). The multiple b-values for each region of interest was averaged, and the resulting data analyzed using in-house R package scripts.
Bisulphite PCR
Approximately 1 lg DNA was subjected to sodium bisulphite treatment and purified using the EZ GOLD methylation kit (ZYMO). Bisulphite-specific primers for each DMR of interest were used with Immolase (Bioline) Taq polymerase at 45 cycles, and the resulting PCR products were cloned into pGEM-T Easy vector (Promega) for subsequent sequencing (for primer sequences see Supplemental Table S1 ; all the Supplemental Data are available online at www.biolreprod.org).
Pyrosequencing Analysis for Methylation Quantification
Approximately 50 ng of bisulphite converted DNA was used for pyrosequencing. Standard bisulphite PCR was used to amplify the Alu Yb8, LINE-1, and a-satellite repeats [25] , and the SLC2A3, PLA2G2A and VEGFA promoters, with the exception that one primer was biotinylated (see Supplemental Table S1 for primer sequences). The entire biotinylated PCR product (diluted to 40 ll) was mixed with 38 ll of PyroMark binding buffer (Qiagen) and 2 ll (10 mg/ml) streptavidin-coated polystyrene beads. After incubation at 658C, DNA was denaturated with 50 ll 0.5 M NaOH. The singlestranded DNA was hybridized to 40-pmol sequencing primers dissolved in 11 ll PyroMark annealing buffer (Qiagen) at 908C. For sequencing, forward primers were designed to the complementary strand. The pyrosequencing reaction was carried out on a PyroMark Q96 instrument. The peak heights were determined using Pyro Q-CpG1.0.9 software (Biotage).
Sequenom Multiplexed Allelic Expression Analysis
We designed a Sequenom iPLEX assay that could genotype both genomic DNA and cDNAs. The quantitative MassARRAY SNP genotyping and MALDI-TOF mass spectrometry was performed by Sequenom Hamburg (a detailed protocol is available on the Sequenom webpage: http://www. sequenom.com/home). The custom assay genotyped 25 imprinted genes with highly polymorphic coding SNPs identified on the hg19 UCSC genome browser (maternally expressed GTL2 rs11160608, H19 rs2839704, NESP rs1800900, PHLDA2 rs13390, ZNF597 rs12737; paternally expressed GPR1 rs3732082, ZDBF2 rs7582864, C19MC rs55765443, DIRAS3 rs11801053,
. Of these 25, only 12 had heterozygous SNPs or were expressed at sufficient levels to determine allelic origin. The placenta samples heterozygous for ZNF597, KCNQ1OT1, IGF2, H19, GTL2, HYMAI, and PLAGL1 were also analyzed using standard RT-PCR and Sanger sequencing (see Supplemental Table S1 for primer sequences).
Statistical Analyses
All the statistics and graphs were produced using R package. Comparison of methylation between tissue groups and gestational ages was carried out using the Limma package and followed by Bonferroni P value correction for multiple comparison tests (cutoff, 0.05). For comparisons between naturally conceived and ART groups, we used Student t-tests and linear regression. Multiple regression models were used to adjust for possible interactions or confounding factors. For box plots, the boxes represent the interquartile ranges and whiskers span 6 3 SD of the mean of control samples. CAMPRUBÍ ET AL.
RESULTS

Imprinted DMRs Show Stable Methylation Profiles in ART Placental Biopsies
In an attempt to assess genomewide methylation associated with imprinted loci, we designed a custom Illumina Veracode Goldengate methylation array, which is based on multiplexed methylation-sensitive, ligation-mediated primer extension to allow for the simultaneous quantification of 384 CpG sites. Full details of the array design and optimization have been described previously [24] . To reduce the complexity of the dataset, we calculated the mean methylation b-values for all the probes mapping within each imprinted DMR, with the resulting methylation values representing two to four independent probes spaced throughout the defined genomic interval. To confirm that the genomic location of the probes mapped within the regions of allelic methylation and that our approach could detect methylation defects, we compared normal leukocyte and placenta DNAs with genomewide paternal UPD (pUPD) and androgenetic hydatidiform mole, respectively. Although these DNA samples are mosaic (genomewide pUPD contribution 85%; androgenetic contribution of molar DNA ;72%), this analysis revealed that the array correctly detected the methylation profiles associated with imprinted DMRs (Fig. 1) .
The methylation profiles at imprinted DMRs for spontaneously conceived placentas were compared the methylation values obtained for placentas from ART, IUGR, and premature births. Samples were considered to have aberrant methylation if the value was outside 63 SD of the mean of the control samples. Using these criteria, all ART, IUGR, and premature placentas had methylation values within the normal range, with multiple regression identifying no significant differences for groups for any fertility or anthropometric parameter. However there was a statistically significant increase in variance for the KvDMR1, PEG3, and MCTS2 DMRs in ART compared to spontaneous conceived placenta samples (Table 2) . Similar results were obtained when individual probes mapping within these DMRs were analyzed separately (Supplemental Tables S2); however, we failed to observe these differences using pyrosequencing that targeted additional CpG sites within the affected regions (Fig. 2) . For additional validation we also performed pyrosequencing targeting the GRB10 and L3MBTL1 DMRs. The results confirmed the lack of significant methylation differences at these regions in ART and IUGR placenta samples, corroborating the custom array results (Supplemental Fig. S1 ). Identical approaches were used with cord blood EPIGENETIC STABILITY FOLLOWING ART samples, for which all samples were comparable to term cord blood controls (Supplemental Tables S3 and S4 ).
Imprinted Genes Show Robust Monoallelic Expression in ART Placental Samples
To ensure that all placenta samples had the correct allelic expression, we performed a Sequenom iPLEX assay that could genotype both genomic DNA and cDNAs (Spontaneous ¼ 73; ART ¼ 23). This was deemed essential as loss-of-imprinting may occur in a DNA methylation independent manner because some placental-specific imprinted genes are regulated by allelic repressive histone modifications [23] .
The quantitative MassARRAY SNP genotyping and MALDI-TOF mass spectrometry was able to quantify 12 imprinted genes with highly informative SNPs. These included the maternally expressed PHLDA2, GTL2, H19, ZNF331, and ZNF597 transcripts and the paternally expressed C19MC, FAM50B, MEST, HYMAI, PLAGL1, IGF2, and KCNQ1OT1 genes. All the samples that were heterozygous at the DNA level were monoallelically expressed, and when informative maternal DNA samples were available, they showed the appropriate parent-of-origin allelic expression ( Fig. 3 ; data not shown).
Epigenetic Profiles in ART Twins and Triplets
On average, one-fifth of IVF pregnancies are multiple gestations compared to one in eighty in women who conceive naturally [26] . This increased frequency of twins and triplets is associated with higher risks of miscarriage, preeclampsia, IUGR and prematurity [27] . Our cohort contained nine twin pairs conceived following ART. All of the placental and cord blood samples from these pregnancies had imprinted methylation comparable to spontaneous conceived singletons and twins.
In addition, our collection had four dichorionic twins and one triplet set discordant for IUGR. Placental samples from these individuals had normal methylation and when informative, monoallelic expression of imprinted transcripts (twin pair 77/78: C19MC, MEST; 151/152: IGF2, PHLDA2; 158/159: IGF2, KCNQ1OT1) (Fig. 3) . These results indicate that despite stability at imprinted regions, differential vulnerability may exist between different embryos and that each embryo may show individual susceptibility to environmental influences.
Methylation at Interspersed Retrotransposable Elements
Pyrosequencing revealed that CpG dinucleotides within asatellite repeats are methylated 66% 6 7.4% in cord blood DNAs and 52% 6 6.8% in placental samples, 84% 6 1.48% and 72% 6 4.2% in ALU-Yb8, and lastly, that LINE-1 repeats were 52.4% 6 0.6% methylated in cord bloods and 33.7% 6 4.8% in placentas. For each repeat element, placental biopsies were relatively hypomethylated compared to cord blood samples (see Supplemental Fig. S2) .
In placental DNA, there was no collective methylation difference between spontaneously conceived and ART samples for ALU-Yb8 (P ¼ 0.756), a-satellites (P ¼ 0.548) or LINE-1 repeats (P ¼ 0.151). Interestingly, the methylation at two of these retrotransposable elements increased with pregnancy duration (ALU-Yb8, R 2 ¼ 0.28, P ¼ 0.02; a-satellites, R 2 ¼ 0.2, P ¼ 0.05) consistent with the previously reported global increases in placental methylation during gestation [28] . In addition, we did not observe any differences between groups for cord blood samples for the three repeat elements (ALUYb8, P ¼ 0.404; a-satellites, P ¼ 0.359; LINE-1, P ¼ 0.113) (see Supplemental Fig. S2 ), suggesting normally maintained retrotranspon methylation and genomic stability.
ART Placentas Show Normal Gestational Age-Dependent Gains of Methylation at Gene Promoters
Our results indicate that methylation of imprinted DMRs is extremely stable following ART, and it is also unaffected in naturally conceived pregnancies complicated with IUGR and/ or prematurity. To ascertain if a more dynamic epigenetic process is altered following ART, we performed bisulphite pyrosequencing at promoters of genes that show temporal placental expression. The expression of SLC2A3, PLA2G2, and VEGFA transcripts decrease with gestational age [29] [30] [31] [32] . The CpG dinucleotide poor promoters associated with SLC2A3 and PLA2G2 show the appropriate accumulative methylation in response to increasing gestational age (SLC2A3: spontaneous, R 2 ¼ 0.38, P , 0.001, and ART, R 2 ¼ 0.18, P , 0.005; PLA2G2: spontaneous, R 2 ¼ 0.41, P , 0.001, and ART, R 2 ¼ 0.25, P , 0.001). Surprisingly the CpG island associated with VEGFA promoter also showed a subtle increases in methylation with gestational age (spontaneous, R 2 ¼ 0.16, P , 0.002; ART, R 2 ¼ 0.15, P , 0.01) despite remaining essentially hypomethylated (spontaneous mean ¼ 1.6%, range ¼ 0%-6%; ART mean ¼ 1.9%, range ¼ 0.05%-4%). This analysis reveals that the methylation at gene promoters also increases during the course of gestation in both spontaneous and ART conceived pregnancies, suggesting that this developmentally regulated process is not disrupted following ART (Fig. 4) .
DISCUSSION
Infertility affects one in six couples, with approximately 5 million children being born as a result of ART throughout the world. Although ART has become a widely accepted therapy to overcome most forms of infertility, there have been concerns about the safety of ART for the resulting children [33] . A series of reports dating back to 2002 raised concerns that there might be an increased incidence of imprinting disorders and growth defects in children conceived by ART [17, 34] . Animal studies have demonstrated biological plausibility of an association for altered epigenetic inheritance in the placenta following IVF and embryo manipulations [35] . In addition, altered growth trajectories due to aberrant imprinting of IGF2R are highlighted by large offspring syndrome in sheep [36] . To address if the increased frequency of growth impairment seen after ART can be attributed to loss-of-imprinting in humans, we undertook an epigenetic genomewide screening of imprinted DMRs comparing placenta and cord blood samples from ART and naturally conceived pregnancies complicated with IUGR and prematurity. We failed to observe imprinting defects associated with IUGR or prematurity in both populations, suggesting that allelic methylation and expression of imprinted genes is faithfully maintained and that ART-associated imprinting defects are restricted to specific syndromes. Previous studies have observed increase variation in placental methylation at imprinted loci following ART [37] , with another study reporting considerable variance in placental methylation and lower H19 methylation in normotensive IUGR [21] . We did not observe this in our cohort. However, the placenta is made up of many cell types, and this variation has been shown to attribute toward variance in allelic methylation at imprinted loci [37] . To overcome this problem, future studies should try and perform methylation profiling on immunoselected villous trophoblast cells as has previously been reported in placenta [38] .
The methylation at retrotransposable elements were all within the normal range and placental methylation dynamics as revealed by the gestational-age gains in methylation at some of these elements and at gene promoters, which occurred normally in the placentas of ART pregnancies. Overall, our results are consistent with smaller-scale studies that failed to identify methylation defects at H19, KCNQ1OT1, SNRPN, and IGF2 or Sat-2 repeats, in gestations of ART children with normal growth parameters [39] [40] [41] [42] [43] . In our study, we did not determine the abundance of the imprinted transcripts that may influence fetal growth. Abnormal transcriptional output of imprinted genes has been reported following ART [44] , and recent studies have suggested that fluctuations in total expression levels of the PHLDA2 gene can have an influence on fetal growth, despite maintained maternal expression [45] . With the advent of genomewide methylation technologies, it will be interesting to analyze if DNA methylation profiles at nonimprinted loci, which may be subject to less strict regulation, show increased variability in individuals conceived following ART.
The role of abnormal methylation, particularly at imprinted domains, in the sperm of infertile patients is often conflicting [46] [47] [48] . Genomewide methylation screens in sperm have found only limited difference between fertile and infertile men. In addition, genomewide analyses have identified subtle changes in histone retention and histone modification at developmentally important transcripts and imprinted genes in sperm of infertile men [49, 50] . However, there is currently EPIGENETIC STABILITY FOLLOWING ART very little evidence to suggest that these abnormal epigenetic profiles are passed on and maintained in offspring. This is because the uniting genomes are subjected to complete reprogramming upon fertilization to give rise to the totipotent blastomeres. Recently, aberrant regulation of PIWI-associated RNAs (piRNAs) has been identified in patients with spermatogenic failure [51] . The downstream effects of aberrant PIWI processing are the defective production of piRNAs and hypomethylation of repetitive sequences in patients. However, in view of the fact that methylation at retrotranspons were normal in all the ART individuals, including those associated with male infertility, this is unlikely to be a common mechanism of infertility. Interestingly piRNAs are involved in the acquisition of paternal methylation at the mouse Rasgrf1 DMR; however, the human orthologue is not imprinted and so we could not determine the interplay between these two mechanisms following ART [52, 53] . It remains a possibility that other classes of noncoding RNAs involved in male gamete production, such as micro-RNAs, may be abnormally abundant in sperm of infertile men and could have potent effects on embryonic mRNA levels because this form of epigenetic transcription control would be subjected to the chromatinbased reprogramming that occurs at the oocyte to embryo transition.
In conclusion, several studies have shown a link between ART and various imprinting disorders including BWS, AS, and possibly retinoblastoma. Our results suggest that ART procedures alone are not sufficient to increase the methylation variation significantly at imprinted domains and that IUGR and prematurity are not associated with aberrant imprinting in either the ART or spontaneously conceived groups.
